Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» KIT inhibitor
KIT inhibitor
Cogent Biosciences, Inc. Announces Pricing of Public Offering, Generating Approximately $150 Million for Precision Therapies Development
Yahoo Finance
Wed, 06/7/23 - 09:49 pm
Cogent Biosciences
KIT inhibitor
public offering